Chemotherapy regimen | Total (cases) | ST-T segment abnormalities | Elevated myocardial enzymes | Arrhythmia | QRS pattern or duration abnormalities | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of events [cases (%)] | χ2 | P value | No. of events [cases (%)] | χ2 | P value | No. of events [cases (%)] | χ2 | P value | No. of events [cases (%)] | χ2 | P value | ||
Anthracycline-based | 22 | 12 (54.5) | 6.977 | 0.008 | 0 (0) | 0.020 | 0.889 | 4 (18.2) | 2.519 | 0.112 | 4 (18.2) | 1.224 | 0.269 |
Taxane-based | 56 | 13 (23.2) | 2.331 | 0.127 | 1 (1.8) | 0.001 | 0.980 | 21 (37.5) | 0.179 | 0.672 | 2 (3.6) | 2.687 | 0.001 |
Anthracycline–taxane-based | 66 | 19 (28.8) | 0.188 | 0.665 | 3 (4.5) | 0.515 | 0.430 | 25 (37.9) | 0.329 | 0.566 | 8 (12.1) | 0.938 | 0.333 |
Others | 3 | 1 (33.3) | 0.000 | 1.000 | 0 | 0.000 | 1.000 | 2 (66.7) | 0.287 | 0.592 | 0 | 0.000 | 1.000 |